Estimation of the macromolecular proton fraction and bound pool T2 in multiple sclerosis

Multiple Sclerosis

Volumn 10, Issue 6, 2004, Pages 607-613

  Davies, G R ^a   Tozer, D J ^a   Cercignani, M ^a   Ramani, A ^a   Dalton, C M ^a   Thompson, A J ^a   Barker, G J ^a,b   Tofts, P S ^a   Miller, D H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Gray matter; Lesions; Magnetization transfer ratio; Multiple sclerosis; Myelin; Normal appearing white matter

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC VALUE; FEMALE; GRAY MATTER; HUMAN; IMAGE PROCESSING; MACROMOLECULE; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL DISABILITY; REPRODUCIBILITY; SENSITIVITY ANALYSIS; WHITE MATTER;

ADULT; AGE FACTORS; AGED; BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROTONS; REPRODUCIBILITY OF RESULTS; SEX FACTORS;

EID: 9744260993     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458504ms1105oa     Document Type: Article

References (28)

1. van Buchem MA, Tofts PS. Magnetization transfer imaging. Neuroimaging Clin N Am 2000; 10: 771-88.
2. Dousset V, Grossman RI, Ramer KN, Schnall MD, Young LH, Gonzalez-Scarano F et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992; 182: 483-91.
3. Filippi M, Campi A, Dousset V, Baratti C, Martinelli V, Canal N et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995; 45: 478-82.
4. van Buchem MA, McGowan JC, Kolson DL, Polansky M, Grossman RI. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn Reson Med 1996; 36: 632-36.
5. Morrison C, Henkelman RM. A model for magnetization transfer in tissues. Magn Reson Med 1995; 33: 475-82.
6. van Waesberghe JH, Kamphorst W, De Groot CJ, van Walderveen MA, Castelijns JA, Ravid R et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999; 46: 747-54.
7. Gareau PJ, Rutt BK, Karlik SJ, Mitchell JR. Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS. J Magn Reson Imaging 2000; 11: 586-95.
8. Henkelman RM, Huang X, Xiang QS, Stanisz GJ, Swanson SD, Bronskill MJ. Quantitative interpretation of magnetization transfer. Magn Reson Med 1993; 29: 759-66.
9. Ramani A, Dalton C, Miller DH, Tofts PS, Barker GJ. Precise estimate of fundamental in vivo MT parameters in human brain in clinically feasible times. Magn Reson Imaging 2002; 20: 721-31.
10. Tozer D, Ramani A, Barker GJ, Davies GR, Miller DH, Tofts PS. Quantitative magnetization transfer mapping of bound protons in multiple sclerosis. Magn Reson Med 2003; 50: 83-91.
11. Sled JG, Pike GB. Quantitative imaging of magnetization transfer exchange and relaxation properties in vivo using MRI. Magn Reson Med 2001; 46: 923-31.
12. Yarnykh VL. Pulsed Z-spectroscopic imaging of cross-relaxation parameters in tissues for human MRI: theory and clinical applications. Magn Reson Med 2002; 47: 929-39.
13. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
14. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 907-11.
15. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
16. Fischer JS, Rudick RA, Cutter GR, Reingold SC. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler 1999; 5: 244-50.
17. Parker GJ, Barker GJ, Tofts PS. Accurate multislice gradient echo T(1) measurement in the presence of non-ideal RF pulse shape and RF field nonuniformity. Magn Reson Med 2001; 45: 838-45.
18. Woods RP, Mazziotta JC, Cherry SR. MRI-PET registration with automated algorithm. J Comput Assist Tomogr 1993; 17: 536-46.
19. Studholme C, Hill DLG, Hawkes DJ. An overlap invariant entropy measure of 3D medical image alignment. Pattern Recognit 1999; 32: 71-86.
20. Sailer M, O'Riordan JI, Thompson AJ, Kingsley DP, MacManus DG, McDonald WI et al. Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination. Neurology 1999; 52: 599-606.
21. Ford B, Bentley J, Du Croz JJ, Hague SJ. The NAG library 'machine'. Softw Pract Exper 1979; 9: 65-72
22. Filippi M, Grossman RI. MRI techniques to monitor MS evolution: the present and the future. Neurology 2002; 58: 1147-53.
23. Lassmann H. Neuropathology in multiple sclerosis: new concepts. Mult Scler 1998; 4: 93-98.
24. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-85.
25. Adams CWM. Pathology of multiple sclerosis: progression of the lesion. Br Med Bull 1977; 33: 15-22.
26. Allen IV, McKeown SR. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 1979; 41: 81-91.
27. Evangelou N, Esiri MM, Smith S, Palace J, Matthews PM. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 2000; 47: 391-95.
28. Stanisz GJ, Webb S, Munro CA, Pun T, Midha R. MR properties of excised neural tissue following experimentally induced inflammation. Magn Reson Med 2004; 51: 473-79.